近距离放射治疗设备市场规模、份额和成长分析（按产品、技术、应用、最终用户和地区）- 2025-2032 年产业预测

近距离放射治疗设备市场规模预计在 2023 年为 8.391 亿美元，预计将从 2024 年的 9.0707 亿美元增长到 2032 年的 16.9139 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.1%。

受癌症发病率上升和对有效治疗方案的需求推动，全球近距离放射治疗市场正在经历显着增长。放射输送系统的技术进步不仅提高了近距离放射治疗的安全性和有效性，而且还导致了诸如施用器、后装器和粒子等产品的多样化。由领先的医疗设备製造商和医疗机构组成的主要市场参与者正在大力投资研发，以创新和推出先进的解决方案。策略性地利用合作、合併和收购来增加市场占有率和扩大产品范围。随着癌症发病率持续上升，市场有望实现持续成长，并有望透过下一代近距离放射治疗设备改善患者的治疗效果和生活品质。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析
• 专利分析

近距离放射治疗设备市场规模（依产品）

• 市场概况
• 近距离放射治疗后荷机
• 近距离放射治疗器
• 其他的

近距离放射治疗设备市场规模（依技术）

• 市场概况
• 低剂量率 (LDR)
• 高剂量率 (HDR)
• 脉衝剂量率 (PDR)

近距离放射治疗设备市场规模（按应用）

• 市场概况
• 摄护腺癌
• 子宫颈癌
• 乳癌
• 妇科癌症
• 其他的

近距离放射治疗设备市场规模（依最终用户）

• 市场概况
• 医院
• 肿瘤中心
• 其他的

近距离放射治疗设备市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Elekta AB（Sweden）
• Eckert & Ziegler BEBIG（Germany）
• Theragenics Corporation（USA）
• Becton, Dickinson and Company（USA）
• iCAD Inc.（USA）
• CIVCO Medical Solutions（USA）
• Sun Nuclear Corporation（USA）
• AngioDynamics Inc.（USA）
• IsoAid LLC（USA）
• Best Medical International（USA）
• IsoRay Medical Inc.（USA）
• BrachySciences（USA）
• Huiheng Medical Inc.（China）
• Panacea Medical Technologies Pvt. Ltd.（India）
• Sensus Healthcare Inc.（USA）
• TheraSphere（Canada）
• Sirtex Medical Limited（Australia）
• Nucletron BV（Netherlands）
• Carl Zeiss Meditec AG（Germany）
• Orfit Industries（Belgium）

结论和建议

Brachytherapy Devices Market size was valued at USD 839.1 million in 2023 and is poised to grow from USD 907.07 million in 2024 to USD 1691.39 million by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global brachytherapy market is experiencing significant growth driven by the rising incidence of cancer and the demand for effective treatment options. Technological advancements in radiation delivery systems have not only increased the safety and effectiveness of brachytherapy but have also diversified the product offerings, including applicators, afterloaders, and seeds. Key market players, consisting of leading medical device manufacturers and healthcare institutions, are heavily investing in research and development to innovate and introduce advanced solutions. Collaboration, mergers, and acquisitions are strategically utilized to enhance market presence and expand product ranges. As the prevalence of cancer continues to rise, the market is poised for sustained growth, promising improved patient outcomes and quality of life through next-generation brachytherapy devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Brachytherapy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Brachytherapy Devices Market Segments Analysis

Global Brachytherapy Devices Market is segmented by Product, Technique, Application, End User and region. Based on Product, the market is segmented into Brachytherapy Afterloader, Brachytherapy Applicators and Others. Based on Technique, the market is segmented into Low Dose Rate (LDR, High Dose Rate (HDR) and Pulse Dose Rate (PDR). Based on Application, the market is segmented into Prostate Cancer, Cervical Cancer, Breast Cancer, Gynaecological Cancer and Others. Based on End User, the market is segmented into Hospitals, Oncology Treatment Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Brachytherapy Devices Market

One of the key factors propelling the growth of the Brachytherapy Devices market is the presence of supportive reimbursement policies for brachytherapy procedures. These reimbursement programs, offered by both government bodies and private insurance companies, incentivize healthcare facilities to incorporate brachytherapy treatments into their services. As a result, this financial backing not only enhances accessibility for patients seeking these therapies but also drives the overall expansion of the market. The assurance of coverage for such procedures plays a vital role in encouraging healthcare providers to adopt and promote brachytherapy, ultimately benefiting patient care and outcomes.

Restraints in the Brachytherapy Devices Market

The Brachytherapy Devices market faces significant constraints due to the necessity for highly skilled medical professionals proficient in radiation oncology and the specialized procedures associated with brachytherapy. A shortage of these trained specialists, especially in specific geographical areas, can hinder the broader acceptance and implementation of brachytherapy treatments. This limitation may ultimately impede market growth, as the availability of qualified personnel is crucial for executing these complex procedures effectively and safely. Consequently, addressing the educational and training gaps in healthcare personnel is key to enhancing the adoption and success of brachytherapy technologies in the medical field.

Market Trends of the Brachytherapy Devices Market

The Brachytherapy Devices market is witnessing a significant upward trend, propelled by the rising global incidence of cancer, particularly among aging populations. As lifestyle changes and environmental factors further exacerbate the prevalence of malignancies, the demand for targeted and effective treatment modalities like brachytherapy is surging. Innovative technological advancements and improved patient outcomes associated with brachytherapy are attracting more clinicians and patients alike, leading to an expanded application range in various cancer types. Consequently, the confluence of these factors is anticipated to catalyze market growth, establishing brachytherapy as a pivotal component in cancer treatment strategies worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Patent Analysis

Global Brachytherapy Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Brachytherapy Afterloader
• Brachytherapy Applicators
• Others

Global Brachytherapy Devices Market Size by Technique & CAGR (2025-2032)

• Market Overview
• Low Dose Rate (LDR)
• High Dose Rate (HDR)
• Pulse Dose Rate (PDR)

Global Brachytherapy Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Prostate Cancer
• Cervical Cancer
• Breast Cancer
• Gynaecological Cancer
• Others

Global Brachytherapy Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Oncology Treatment Centres
• Others

Global Brachytherapy Devices Market Size & CAGR (2025-2032)

• North America (Product, Technique, Application, End User)
  • US
  • Canada
• Europe (Product, Technique, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technique, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technique, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technique, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler BEBIG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theragenics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iCAD Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIVCO Medical Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Nuclear Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IsoAid LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Medical International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IsoRay Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrachySciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huiheng Medical Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Panacea Medical Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensus Healthcare Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TheraSphere (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nucletron B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orfit Industries (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations